Definition of Terms.
Section 3
Sec. 3. Definition of Terms.—The following terms are herein defined for purposes of this Act: "Generic Name or Generic Terminology" is the identification of drugs and medicines by their scientifically and internationally recognized active ingredients or by their official generic name as determined by the Bureau of Food and Drugs of the Department of Health. "Active Ingredient" is the chemical component responsible for the claimed, therapeutic effect of the pharmaceutical product. "Chemical Name" is the description of the chemical structure of the drug or medicine and serves as the complete identification of a compound. "Drug Product" is the finished product form that contains the active ingredients, generally but not necessarily in association with inactive ingredients. "Drug Establishment" is any organization or company involved in the manufacture, importation, repacking and/or distribution of drugs or medicines. "Drug Outlets" means drugstores, pharmacies, and any other business establishments which sell drugs or medicines. "Essential Drugs List" or "National Drug Formulary" is a list of drugs prepared and periodically updated by the Department of Health on the basis of health conditions obtaining in the Philippines as well as on internationally accepted criteria. It shall consist of a core list and a complementary list "Core List" is a list of drugs that meets the health care needs of the majority of the population. "Complementary List" is a list of alternative drugs used when there is no response to the core essential drug or when there is a hypersensitivity reaction to the core essential drug or when, for one reason or another, the core essential drug cannot be given. "Brand Name" is the proprietary name given by the manufacturer to distinguish its product from those of competitors. "Generic Drugs" are drugs not covered by patent protection and which are labeled solely by their international non-proprietary or generic name.